257 related articles for article (PubMed ID: 24706428)
1. Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
Torun E; Gökçe S; Ozgen İT; Aydın S; Cesur Y
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):667-75. PubMed ID: 24706428
[TBL] [Abstract][Full Text] [Related]
2. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease.
Pirgon Ö; Bilgin H; Çekmez F; Kurku H; Dündar BN
J Clin Res Pediatr Endocrinol; 2013; 5(1):33-9. PubMed ID: 23367495
[TBL] [Abstract][Full Text] [Related]
3. Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.
Ferré N; Feliu A; García-Heredia A; Marsillach J; París N; Zaragoza-Jordana M; Mackness B; Mackness M; Escribano J; Closa-Monasterolo R; Joven J; Camps J
Clin Biochem; 2013 Dec; 46(18):1830-6. PubMed ID: 24028901
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
[TBL] [Abstract][Full Text] [Related]
5. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
[TBL] [Abstract][Full Text] [Related]
6. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease.
Pirgon O; Cekmez F; Bilgin H; Eren E; Dundar B
Obes Res Clin Pract; 2013; 7(4):e275-83. PubMed ID: 24306155
[TBL] [Abstract][Full Text] [Related]
7. Oxidative Stress Status in Childhood Obesity: A Potential Risk Predictor.
Kilic E; Özer ÖF; Erek Toprak A; Erman H; Torun E; Kesgin Ayhan S; Caglar HG; Selek S; Kocyigit A
Med Sci Monit; 2016 Oct; 22():3673-3679. PubMed ID: 27733746
[TBL] [Abstract][Full Text] [Related]
8. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
9. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
Sayın O; Tokgöz Y; Arslan N
J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
[TBL] [Abstract][Full Text] [Related]
10. Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.
Tabur S; Torun AN; Sabuncu T; Turan MN; Celik H; Ocak AR; Aksoy N
Eur J Endocrinol; 2010 Mar; 162(3):535-41. PubMed ID: 20022940
[TBL] [Abstract][Full Text] [Related]
11. Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease.
Sert A; Pirgon O; Aypar E; Yilmaz H; Odabas D
J Pediatr Endocrinol Metab; 2012; 25(9-10):927-34. PubMed ID: 23426822
[TBL] [Abstract][Full Text] [Related]
12. Thyroid function in obese children with non-alcoholic fatty liver disease.
Bilgin H; Pirgon Ö
J Clin Res Pediatr Endocrinol; 2014 Sep; 6(3):152-7. PubMed ID: 25241608
[TBL] [Abstract][Full Text] [Related]
13. Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome.
Eren E; Abuhandan M; Solmaz A; Taşkın A
J Clin Res Pediatr Endocrinol; 2014 Sep; 6(3):163-8. PubMed ID: 25241610
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
[TBL] [Abstract][Full Text] [Related]
15. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Cardiovascular Parameters in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease.
Eklioğlu BS; Atabek ME; Akyürek N; Alp H
J Clin Res Pediatr Endocrinol; 2015 Sep; 7(3):222-7. PubMed ID: 26831557
[TBL] [Abstract][Full Text] [Related]
17. Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease.
Amin S; El Amrousy D; Elrifaey S; Gamal R; Hodeib H
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):117-121. PubMed ID: 28991837
[TBL] [Abstract][Full Text] [Related]
18. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M
Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
Torun AN; Vural M; Cece H; Camuzcuoglu H; Toy H; Aksoy N
Gynecol Endocrinol; 2011 Dec; 27(12):988-92. PubMed ID: 21557696
[TBL] [Abstract][Full Text] [Related]
20. Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Samy W; Hassanian MA
Arab J Gastroenterol; 2011 Jun; 12(2):80-5. PubMed ID: 21684478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
